According to Context Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.17. In 2022 the company made an earnings per share (EPS) of -$0.93 an increase over its 2021 EPS that were of -$1.22.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.17 | 25.81% |
2022 | -$0.93 | -23.91% |
2021 | -$1.22 | -659.67% |
2020 | $0.22 |